The Immunophenotyping Changes of Peripheral CD4+ T Lymphocytes and Inflammatory Markers of Class III Obesity Subjects After Laparoscopic Gastric Sleeve Surgery - A Follow-Up Study by Rizk, Nasser M et al.
O R I G I N A L  R E S E A R C H
The Immunophenotyping Changes of Peripheral 
CD4+ T Lymphocytes and Inflammatory Markers 
of Class III Obesity Subjects After Laparoscopic 
Gastric Sleeve Surgery – A Follow-Up Study
Nasser M Rizk 1–3 
Amina Fadel1 
Wasaif AlShammari 1 
Noura Younes4 
Moataz Bashah5
1Biomedical Sciences Department- 
College of Health Sciences, QU Health— 
Qatar University, 2Biomedical Research 
Center, Qatar University, 3Biomedical 
and Pharmaceutical Research Unit, QU 
Health—Qatar University, 4Clinical 
Chemistry Lab, Hamad Medical 
Corporation, Doha, Qatar; 5Metabolic 
Unit, Surgery Department, Hammed 
Medical Corporation (HMC), Doha, 
Qatar 
Purpose: Obesity is a chronic disorder characterized by a low-grade inflammatory state and 
immune cell irregularities. The study aimed to follow up on the changes in the peripheral 
CD4+ T lymphocytes and the pro-inflammatory cytokines; IL-6, TNF-alpha, MCP-1, and IL- 
10 at baseline and 12 weeks post-surgical intervention by the laparoscopic gastric sleeve 
(LGS) in morbidly obese patients (class III obesity subjects).
Materials and Methods: A prospective longitudinal research included 24 class III obesity 
subjects with a BMI > 40 kg/m2. The subjects were enrolled from the Metabolic/Surgical 
Department at Hamad Medical Corporation (HMC)-Qatar. Fasting blood samples were 
collected at admission to LGS for weight loss and after 12 weeks of LGS. The immunophe-
notype of CD4+ T-cell populations; naïve (CD45RA+and CD27+), central memory T cells 
(CD45RO+ and CD27+), and effector memory (CD45RO+and CD27−) and T-regulatory cell 
(CD4+CD25+ FoxP3+) were identified using flow cytometry. Plasma pro-inflammatory 
cytokines and adipokines were evaluated. A control group of lean subjects was used to 
compare changes of T-regulatory and inflammatory biomarkers with postoperative changes 
in obese patients.
Results: The means (SD) of age and BMI of class III obesity subjects was 32.32 (8.36) years 
and 49.02 (6.28) kg/m2, respectively. LGS caused a significant reduction in BMI by 32%, 
p<0.0001. LGS intervention significantly decreased CD4+ T-lymphocytes and effector 
memory (TEM) cells but increased T-regulatory (Treg), naïve, and central memory (TCM) 
cells, with all p values < 0.05. The increase of Treg cells postoperative is significantly lower 
compared to lean subjects, p < 0.05. A significant reduction of plasma IL-6, TNF-α, and 
MCP-1, but IL-10 significantly increased after LGS, with all p<0.05. Adiponectin/leptin ratio 
improved after LGS by 2.9 folds, p<0.0001.
Conclusion: Weight loss by LGS accomplished a substantial rise of Treg and decreased EM 
T-lymphocytes with a shift from pro-inflammatory to the anti-inflammatory pattern.
Keywords: class III obesity, immunity, peripheral CD4+ T-lymphocytes, T-regulatory cells, 
follow up, laparoscope gastric sleeve surgery
Plain Summary
Obesity is a chronic disorder associated with comorbidities such as diabetes, 
hypertension, atherosclerosis, cardiovascular diseases, and cancers. Obese subjects 
with BMI ≥40kg/m2 are at high risk for morbidity and mortality, and nowadays, for 
COVID-19 infections. These obese subjects are treated nowadays with metabolic 
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bariatric surgery, most commonly laparoscopic gastric 
sleeve (LGS) surgery, which showed marked success. 
The current study investigated the profile of circulating 
immune system CD4+ cell subpopulations at baseline and 
12 weeks after LGS in these patients. The results demon-
strated a shift of immune cells of CD4+ lymphocytes 
towards upregulation of T regulatory cells, naïve, central 
memory cells with downregulation of effective memory 
cells. LGS alleviated the obesity-associated inflammation 
and insulin resistant states associated with morbid obesity.
Introduction
Obesity is a chronic disease associated with inflammatory 
responses in adipose tissue associated with metabolic and 
vascular abnormalities, such as insulin resistance, fatty 
liver, arteriosclerosis, and cardiovascular risks.1 Obesity 
is increasing worldwide in prevalence among the develop-
ing and developed countries, which need medical manage-
ment to prevent its associated comorbidities.2 Although 
class III obesity, especially with BMI>40 Kg/m2, is asso-
ciated with several comorbidities, it can be controlled, and 
the consequences could be prevented.3 Nowadays, suc-
cessful weight loss intervention for class III obesity 
(BMI >40 Kg/m2) with significant comorbidities is the 
metabolic/bariatric surgery, which is one of the most effec-
tive interventions compared to other management and has 
proved as effective therapy with excellent results.4
Previous studies demonstrated that inflamed adipose 
tissue in obese mice was associated with increased macro-
phages and T lymphocytes. The infiltration of those 
immune cells into the adipose tissue most likely causing 
the inflammation.5 Previous studies also suggested that the 
increased number of inflammatory cells and their secre-
tions such as cytokines induced an increased rate in differ-
entiation and proliferation of adipocytes followed by fat 
accumulation, obesity, insulin resistance, and increased 
risks to cardiometabolic syndrome.6
The T lymphocytes in visceral adipose tissue (VAT) of 
obese rodents and humans were postulated to play a role in 
obesity-provoked inflammation.7 Several studies demon-
strated that in the diet-induced obese mice by a high-fat 
diet, the increased quantities of T lymphocytes are mostly 
preceding the macrophage infiltration in VAT and playing 
significant roles in the recruitment of the macrophage 
recruitment and induction of VAT inflammation.8,9
Regulatory T (Treg) cell is one of the main regulatory 
subsets among CD4+ T lymphocytes, characterized by 
a specific molecular marker as CD4+ CD25+ Foxp3+. 
Although several effector T cell subcategories are involved 
in adipose tissue inflammation, Treg cells are concerned 
with maintaining the AT homeostasis.10
Moreover, a previous study of CD4+T lymphocytes in 
Class III obese patients’ blood demonstrated an increase in 
peripheral blood CD4+ T Cells with a shift toward natural 
CD4+CD25+FoxP3+ T-regulatory associated with anti- 
inflammatory profile with the increased plasma level of 
cytokines IL-7 and CCL5.3
The cardiometabolic indorsing of obesity is not only 
local changes of AT microenvironment but also system-
atically through the dysregulated profile of the circulating 
immune cells and inflammatory biomarkers that could 
reflect adipose tissue pathology such as inflammation. 
However, no data are available concerning the alterations 
in circulating CD4+ T-lymphocyte immunophenotyping 
with class III obese subjects after LGS intervention. The 
present study’s main aim is to investigate the alterations of 
the immune phenotype of CD4+ T-lymphocyte subpopula-
tions in class III obesity undertaking bariatric surgery and 
after 12 weeks of the intervention. The study also investi-
gated parallel changes of adipokines, metabolic, and 




A prospective longitudinal study was performed on a total of 
24 class III obesity subjects with BMI of (38.8–64.0 kg/m2) 
of both sex (15 females and 9 males) with age ranges 
between 10 and 38 years in the Metabolic/Surgical 
Department at Hamad Medical Corporation (HMC). 
Another healthy control group (n=28) with a BMI of (32.91 
± 6.67 kg/m2) was used to compare healthy and class III 
obesity groups. The healthy control group was recruited from 
students and employees at Qatar University with BMI from 
18.50–24.00 and from 30.00 to 34.99 kg/m2, respectively. 
Among the cohort class III obesity study subjects with BMI 
≥40 kg/m2 at the baseline, eight subjects were diabetic 
(33.3%) based on diagnostic criteria of ADA,11 and eleven 
subjects had metabolic syndrome (45.8%) according to ATP 
III.12 Insulin resistance was calculated by HOMA-IR,13 with 
4.8 as a cut-off point (75th percentile).14 All subjects 
included in the current study were excluded if they had the 
immunologic/autoimmune disorder, severe renal and liver 
impairment, thyroid disorders, and cancer. Venous blood 
samples (10 mL) were collected from all consented subjects 
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at admission to surgery consecutively performed laparo-
scopic gastric sleeve (LGS) operation for weight loss by 
authorized consultants surgeons at Bariatric Metabolic 
Surgery, HMC, Doha-Qatar. Another blood specimen was 
obtained after three months of follow up. A complete blood 
picture was assessed at HMC labs. Plasma samples were 
used for biochemical analysis, including circulating levels 
of glucose, lipid profile, liver, and kidney functions, hormo-
nal parameters (c-peptide, insulin, leptin, and adiponectin), 
hsCRP, and blood cell immune markers (CD4+ T lymphocyte 
(Treg, naïve, central memory [TCM], and effector memory 
[TEM]) and pro-inflammatory cytokines and chemokine 
[MCP-1, TNF-alpha, IL-6, and IL-10]. Adipose tissue biopsy 
from visceral white adipose tissue (VAT) (1g) was collected 
during LGS surgery (first visit) and was used to count the 
adipose tissue macrophages to characterize the M1/M2 
polarization. All CD markers and flow cytometry reagents 
used for immunophenotyping were purchased from (BD, 
Bioscience, USA) unless otherwise mentioned (Table S1). 
Multiplex Elisa kits from (Millipore, Merck, Germany) were 
used to measure adipokines and inflammatory markers. 
Other chemicals were obtained from (Sigma-Aldrich, 
Germany) unless mentioned elsewhere. The study was 
approved by the Institutional Review Boards of the Hamad 
Medical Corporation and Qatar University (HMC # 12199/ 
12, and QU-IRB# 279-A-2104 for class III obesity subjects, 
and QU-IRB#683-EA/116 for the control group, respec-
tively). After a full explanation of the purpose, nature, and 
risk of all procedures used, written informed consent was 
taken from all subjects for acceptance in this study. The study 
was accomplished according to the principles stated in the 
Declaration of Helsinki.
Blood Collection and Assays
A total of 10 mL of venous blood was obtained from 
a peripheral vein and was subjected for centrifugation and 
subsequent plasma separation and eventual central storage at 
−80°C for further analysis of MCP-1, TNF-alpha, IL-6, 
leptin, adiponectin, and IL-10. Another 10 mL of the venous 
blood sample was collected into EDTA tube and stored at 
room temperature. It was used for determining the total and 
differential leukocyte count (TLC and DLC), CD4+ 
T-lymphocytes, and its populations and cell immune markers 
(CD4+ T cell and its subpopulations) using flow cytometry. 
Plasma samples were used for biochemical analysis, includ-
ing glucose, lipid profile, liver, kidney functions, hormonal 
parameters (c-peptide and insulin), and were performed at 
HMC labs. Assessment of MCP-1, TNF-alpha, IL-6, leptin, 
adiponectin, and IL-10 was performed in the Biomedical 
Research Center (BRC) labs at Qatar University using 
Luminex 200 by the multiplex technique according to the 
manufacturer’s protocol. Adipokines and cytokines were 
measured by the Multiplex Elisa technique using magnetic 
beads (HADK2MAG-61K, MADCYMAG-72K from 
Millipore), IL-10 (MPXHCYTO-60K-06 from Millipore), 
and Elisa was used for hsCRP (ab181416 from Abcam). 
The assay was performed based upon the manufacturer’s 
protocol, as previously published by our lab.15
Flow Cytometry
Staining and procedures were accomplished according to the 
manufacturer’s protocol. In short, blood specimens were 
collected on EDTA tube and stored at a constant temperature 
of 4°C, and analyzed within two hours of collection. For 
immunophenotyping CD4+ T-cell population cells, the cir-
culating CD 45+/CD4 was counted using (BD LSRFortessa 
TM Cell Analyzer cat no. 649225, BD FACSDiva Software), 
which acquired at least 5×105 events, Supplementary 
Figures. CD4+ T-cell subpopulations were defined as naïve 
(CD45RA+andCD27+), central memory T cells 
(CD45RO+andCD27+), effector/peripheral memory 
(CD45RO+and CD27−) and Treg cells were defined as CD4 
+CD25+FoxP3+, as previously published.3,16 Briefly, 100µL 
blood was incubated with 10µL PerCP-conjugated anti- 
human CD45 monoclonal antibody (Becton Dickinson 
Biosciences), 10µL PerCP-conjugated anti-human CD4 
monoclonal antibody APC (Becton Dickinson Biosciences, 
USA), and 10µL allophycocyanin-conjugated anti-human 
CD27 APC (Becton Dickinson Biosciences, CA, USA) for 
30 min at 4°C.3,16,17 Briefly, 100µL blood was incubated 
with 10µL PerCP-conjugated anti-human CD45 monoclonal 
antibody (Becton Dickinson Biosciences), 10µL PerCP- 
conjugated anti-human CD4 monoclonal antibody APC 
(Becton Dickinson Biosciences, USA), and 10µL allophyco-
cyanin-conjugated anti-human CD27 APC (Becton 
Dickinson Biosciences, CA, USA) for 30 min at 4°C. The 
number of peripheral blood cells, which was positive for CD 
markers, was decided by a three-dimensional fluorescence 
dot-plot analysis of the samples, following the proper gating. 
We primarily gated CD45+ peripheral blood cells, then gat-
ing with 7-AAD for viability, then gated for CD4+ blood 
cells in the lymphocyte cell section, and afterward analyzed 
the resulting population for expression of CD27 (Figure S1). 
Data were handled using a software program (BD FACSDiva 
Software, BD Bioscience). Cell counts were presented as the 
number of cells per 106 cytometric events and displayed as 
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a percentage of total CD4+ T lymphocytes. The technician 
performed all assays were blinded to the medical condition of 
participants. For detecting FoxP3 T regulatory cell, in a tube 
containing 100-μL of the buffy coat, a 20-μL from each 
reagent (BD-PE CD25 and BD-FITC CD4) was added and 
incubated for 20 minutes at room temperature (RT) in the 
dark. After that, 1 mL of “PE Pharmingen Stain Buffer 
(FBS)” was added to the tubes and centrifuged for 10 minutes 
at 1500 rpm. A clear pallet was observed at the bottom of the 
tube; the supernatant FBS was aspirated. Then, while adding 
1 mL of “PE-Human FoxP3 Buffer A”, the pellet was resus-
pended gently; then incubate the tubes for 10 minutes in the 
dark at RT. Following that, the sample was centrifuged at 
3000 rpm for 5 minutes. The supernatant was decanted, and 
0.5 mL of buffer C was added to tubes followed by tube 
incubation. Buffer C is a mixture of “60-μL of PE-Human 
FoxP3 Buffer A and 940-μL of PE-Human FoxP3 Buffer B”. 
Repeating the staining “FBS” step, 20-μL was added of PE- 
Mouse anti-Human Foxp3 antibody and incubated in the 
dark for 30 minutes at RT. Finally, 500-μL of FBS was 
added, and the results were analyzed using a flow cytometer. 
The process of flow cytometry was based on previous 
publications,3,16,17 as shown in Supplementary Figures 
(Figure S2).
Stromal Vascular Isolation and at 
Macrophages
Visceral adipose tissues were obtained from the omentum 
during LGS and placed immediately in DMEM supplemen-
ted with 20 mmol/l HEPES (Sigma) and transferred to the lab 
within 2 h. Upon receiving the sample, adipose tissue was 
weighed and minced using razors, scissors, and tongs in the 
Biosafety level 2 hoods. It was then washed with PBS+1% 
antibiotic wash buffer. Warmed Type 1 Collagenase is then 
added according to the tissue’s weight, and tubes were cov-
ered with parafilm and placed in the shaking water bath for 60 
minutes. After digestion, the sample is centrifuged to get 
a pellet of Stromal-Vascular (SV) cells with a transparent 
lipid layer on the top. The lipid layer is removed, and the 
pellet is washed twice with warmed PBS+1%BSA. The RBC 
lysis solution is added, and the sample is centrifuged after 10 
mins. The supernatant is then removed, and the sample is 
mixed thoroughly with stromal medium and filtered through 
a (190 µM) sieve filter. The filtrate was then resuspended in 
one mL stromal medium and processed for flow cytometry. 
Cell number and viability were assayed using 
a hemocytometer and trypan blue. The flow cytometry 
process was based on previous publications using CD206 
and CD11b markers to identify M1/M2 polarization, as pre-
viously published.18
Statistical Analysis
The expression of data is presented as mean ± SD unless 
otherwise mentioned. All data were checked for outliers, 
skewness, and normality and transformed when necessary. 
We compared baseline parameters between class 111 obese 
subjects before and after surgery using appropriately 
paired student-t or Mann–Whitney/Wilcoxon (if the nor-
mality assumption was violated). One-way analysis of 
variance or Wilcoxon test (if the normality assumption 
was violated) to compare parameters between three groups 
followed by Dunn's test for mutiple compariosns . The 
Chi-square test evaluated the distribution of categorical 
variables. Spearman correlation coefficient (r) was applied 
to study the study variables’ correlations with the immune 
cells and BMI. The cut-off value for significance is a two- 
tailed level p < 0.05. All analysis was achieved by employ-
ing the SPSS program for Windows (version 23 statistical 
software; Texas instruments, IL, USA), and Graph Pad 
Prism was utilized to draw the figures (version 8, for 
Win, Graph Pad Software, La Jolla California USA).
Results
Effect of LGS Surgery on Anthropometric, 
Clinical, and Biochemical Characters of the 
Morbidly Obese Subjects
A clinical cohort of 24 morbidly obese subjects was 
recruited. The cohort had a range of ages from 19 to 48 
years, with BMI, ranges from 38.8 to 64.0 kg/m2. 
Participants were evaluated for blood pressure, glucose, 
insulin, lipid profile, adipokines, and inflammatory mar-
kers and followed up after 12 weeks of LGS. Liver and 
renal functions were evaluated; aspartate transaminase 
(AST) was 34.64 (16.44)U/L, and alanine transaminase 
(ALT) was 31.72 (27.33) U/L, and creatinine was 60.91 
(10.54) μmol/L. Cortisol was evaluated to exclude endo-
crine disorders, and its concertation was 301.75 (134.04) 
nmol/l. Initially, 33.3% of morbidly obese subjects had 
type 2 DM (T2DM), and 67.0% had fasting hyperglyce-
mia. Among the cohort, 29.0% had dyslipidemia, 90.0% 
had increased WC above cut off values, and 33.0% had 
hypertension. Among the cohort study, 62.5% had insulin 
resistance (IR), and the percentage of metabolic syndrome 
(MeS) was 54.0%. Table 1 describes the clinical and 
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biochemical data of the study subjects. Females were more 
frequent in this study, 62.5% than the male gender. After 
LGS surgery, the study subjects’ follow-up revealed that 
body weight, BMI (Table 1), and waist circumference 
were significantly reduced by 36.0%, 32.6%, and 10.0% 
of the initial measurements, respectively, with p<0.0001. 
Of note, all biochemical parameters of glucose homeosta-
sis, such as glucose, HbA1C, insulin, and insulin resis-
tance, were significantly reduced after LGS. A significant 
reduction of TG and LDL while increasing HDL-C post- 
LCS surgery was detected, p< 0.05. Further, LGS surgery 
significantly reduced the percentage of metabolic syn-
drome components among the cohort subjects; WC from 
(92.0% to 67.0%); dyslipidemia from (29.0% to 14.0%); 
hyperglycemia from (75.0% to 37.5%), HOMA-IR from 
(62.5% to 45.8%), diabetes from (33.3% to 25.0%) and 
hypertension from (33.0% to 4.0%), all with (p<0.05). We 
also compared the demographic and biochemical data with 
healthy control subjects of lean and obese subjects to 
illustrate the changes after the LGS of class III obesity 
subjects. Furthermore, we investigated if the clinical and 
metabolic changes after LGS of class 111 obesity could 
improve; therefore, we recruited healthy lean and obese 
subjects as control groups for comparison. Table 2 shows 
that the demographic, clinical, and biochemical parameters 
were compared in healthy lean and obese subjects with the 
class III obesity group after 12 weeks post-LGS. The data 
showed that BW, BMI, and WC were significantly differ-
ent between healthy lean controls (P≤0.05), while these 
parameters were not significantly different with the healthy 
obese subjects (P>0.05). Meanwhile, the following para-
meters, WC; TC; TG; LDL; insulin; HOMA-IR; leptin; 
MCP-1; and IL-6 (P≤0.05), were significantly higher in 
the class III obesity group after LGS than lean subjects, 
while IL-10 showed opposite changes. However, class III 
obesity group had significantly higher values for TC, insu-
lin, and HOMA-IR than healthy obese subjects (P≤0.05), 
while IL-10 showed opposite changes.
Effect of LGS Surgery on Circulating 
Concentrations of Adipokines, hsCRP 
Pro-Inflammatory Cytokines, and 
Chemokines in Class III Obesity Group
To gain more about the effect of LGS on biomarkers 
related to obesity and inflammation, we evaluated the 
effect of LGS on the concentrations of the following 
biomarkers in the plasma; acute phase protein (hsCRP), 
adipokines (leptin and adiponectin), pro-inflammatory 
cytokines (TNF-α, IL-6, and IL-10) and chemokine 
(MCP-1). Figure 1A, displays a significant reduction 
of leptin (Mean and SEM in ng/mL) from pre-LGS of 
Table 1 The Clinical, Hormonal, and Metabolic Characteristics of Study Subjects at Baseline and After 12 Weeks of the Laparoscopic 
Sleeve Gastrectomy (LGS)
Variables Basal State (24) Before LGS 3 Months (24) After LGS P value
Age (years) 32.32 (8.36) 32.45 (8.50) 0.867
Sex F/M (n, %) 15 (62.5%)/9 (37.5%) 15 (62.5%)/9 (37.5%) 0.859
Weight (kg) 136.56 (23.52) 87.38(15.94) < 0.0001
BMI (kg/m2) 49.02 (6.28) 33.06(4.68) < 0.0001
Waist circumference (cm) 121.16 (21.48) 109.00(21.38) < 0.0001
SBP (mmHg) 117.17 (12.61) 115.21 (11.10) 0.261
DBP (mmHg) 80.72 (9.28) 78.12 (8.35) 0.247
Glucose (mM) 6.33 (1.14) 5.75 (1.04) 0.022
Insulin (mIU/l) 26.71 (12.41) 18.75 (11.95) 0.005
C-peptide (ng/mL) 3.09 (0.84) 2.7105 (0.75) 0.030
HbA1C% 6.47 (1.14) 6.09 (1.01) 0.005
TC (mM) 5.17 (1.06) 5.08 (1.12) 0.061
TG (mM) 1.28 (0.51) 1.15 (0.48) 0.004
HDL-C (mM) 1.12 (0.38) 1.25 (0.43) 0.050
LDL-C (mM) 3.51 (0.97) 3.37 (0.99) < 0.0001
HOMA-IR 6.09 (2.64) 4.02 (2.45) < 0.0001
Notes: Data are presented as mean and (SD) for the continuous data and numbers and (%) for categorical data. Two-tailed p value is significant at ≤0.05. 
Abbreviations: BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1C, hemoglobin A1c; TC, total 
cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment of insulin 
resistance.
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28.20 (7.02) compared to post-LGS of 18.23 (5.94), p< 
0.0001, and hsCRP (pg/mL) from pre-LGS level of 
4.62 (1.22) to post-LGS of 3.14 (1.17), p=0.002. On 
the contrary, LGS significantly increased the plasma 
concentrations of adiponectin (µg/mL) from pre-LGS 
of 6.12 (1.48) to post-LGS of 10.49 (2.71), p< 0.0001. 
Moreover, adiponectin/leptin ratio increased after LGS 
by 2.9 folds from 0.23±0.09 at pre-LGS to 0.67±0.39 
after LGS, p< 0.0001. Figure 1B, demonstrated signifi-
cant changes of the markers from pre-LGS to post-LGS 
of M1 polarization including, TNF-α from (3.51±0.29 
to 2.84±0.24 pg/mL), IL-6 from (1.51±0.16 to 1.10 
±0.10 pg/mL) and MCP-1 (288.3±26.8 to 261.5±27.3 
pg/mL) with p=0.021, p<0.0001, and p=0.012, respec-
tively. IL-10, a marker of M2 polarization, significantly 
increased from (0.56±0.05 to 0.74±0.06 pg/mL) after 
LGS with p<0.0001. Therefore, the data showed a shift 
from M1 to M2 polarization with enhanced adiponec-
tin/leptin ratio, reflecting a systemic improvement of 
adipose tissue inflammation.
Adipose Tissue Macrophages in Obese 
Subjects
To demonstrate the macrophage polarization M1 and M2 
in the adipose tissue, the distribution of CD206/CD11b+ 
was evaluated in VAT of class III obesity subjects at base-
line obtained during LGS. Of note, the expression of 
CD11b+ macrophages expression (M1 marker) was sig-
nificantly higher by ≈8.3 folds than CD206+ (M2 marker) 
with p=0.003 while mixed (CD11b+ and CD206+) were 
significantly higher by 4.3 folds than CD206+ (M2 mar-
ker), p=0.031 as shown in Figure 2.
Effect of LGS on Total White Blood Cell 
Count
Total white blood cell count showed a non-significant 
difference in the total count and differential count of 
granulocytes, lymphocytes, and monocytes before and 
after LGS, though a slight decline was observed among 
lymphocytes p=0.244, as shown in Figure 3.
Table 2 Comparison Between Healthy Control Subjects at Baseline and Morbidly Obese Subjects Before and After LGS
Variable Healthy Control Class III Obesity
Lean (n=14) Obese (n=14) After LGS (n=24)
Age (years) 25.6 ± 6.55 32.38 ± 8.21 32.32±8.36
Weight (kg) 56.00 ± 2.65 97.02 ± 18.05 87.38± 15.94* Ø
Height (cm) 167.34 ± 4.27 161.48 ± 17.11 164.29 ±9.83
BMI (kg/m2) 20.04 ± 1.07 34.21 ± 3.29 33.06±4.68*
SBP (mmHg) 114.00 ± 6.96 118.33 ± 5.51 115.21± 11.10
DBP (mmHg) 83.6 ± 2.30 81.25 ± 8.27 78.12±8.35
Waist Circumference (cm) 74.6 ± 0.55 107.63 ± 6.47∞ 109.00± 21.38*
Glucose (mM) 4.16±0.16 4.99±0.61 5.75± 1.04
Insulin (mIU/l) 6.55 ± 3.33 7.76 ± 6.93 18.75 ±11.95 * Ø
TC (mM) 3.27± 2.13 3.37 ±2.19 5.08± 1.12* Ø
TG (mM) 0.93±0.15 1.17±0.29∞ 1.15 ±0.48*
HDL-C (mM) 1.21±0.19 1.14±0.34 1.25 ±0.43
LDL-C (mM) 1.62±0.42 2.20±0.35∞ 3.37±0.99* Ø
HOMA-IR 1.45± 1.33 1.49 ± 0.85 4.02 ±2.45* Ø
Il-10 (pg/mL) 3.77 ± 1.30 2.92 ± 0.63 0.74±0.32* Ø
Leptin (ng/mL) 8.21±4.45 25.62±6.34∞ 18.34±5.84*
Il-6 (pg/mL) 0.74 ± 0.21 1.16 ± 0.57∞ 1.11±0.53*
MCP-1 (pg/mL) 96.96 ± 5.30 141.85 ± 81.64 261.6±27.92* Ø
Notes: Data are presented as mean and (SD) for the continuous data and numbers and (%) for categorical data. The two-tailed p value is significant at ≤0.05. *P value is 
significant between Class III obesity subjects after LGS and lean subjects. Ø P value is significant between Class III obesity subjects after LGS and obese healthy subjects. 
∞P value is significant between obese healthy subjects and lean subjects. 
Abbreviations: BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1C, hemoglobin A1c; TC, total 
cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment of insulin 
resistance; IL, interleukin.
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Effect of LGS on CD4+ Lymphocytes and 
Subpopulations
Figure 4 displays the effect of LGS on the CD4+ 
T-lymphocytes and its subpopulations of T regulatory, 
naïve, effector memory (TEM) and central memory 
(TCM) cells by flow cytometry on isolated polymorpho-
nuclear leukocytes (PMNLs). LGS significantly decreased 
















































































































Figure 1 Adipokines, hsCRP, and cytokines change after 12 weeks of LGS. (A) Scatter dot plot represents mean and SEM of leptin, adiponectin, and hsCRP, before and after 
LGS, in the class III obesity group. *p value (after LGS) is significantly different than (before LGS). Two-tailed p value is significant at ≤0.05. (B) The scatter dot plot represents 
the mean and SEM of TNF-α-α, IL-6, IL-10, MCP-1 before (baseline) and after LGS in the class III obesity group. *p value (after LGS) is significantly different than (before 
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CD206   - + +
ns
A       B
Figure 2 Distribution of CD206/CD 11b in visceral adipose tissue (VAT) of obese subjects at baseline. (A) A representative of flow cytometry for visceral adipose tissue 
(VAT) macrophages expressing CD206 and CD11b cells with percentages in different regions of the class III obesity group. (B) Bars represent the mean and SEM of VAT 
macrophages based on the expression of CD11b+ (M1) and CD206+ (M2). *p value for (CD206-, CD11b+) is significantly different than (CD206+, CD11b-). **p value for 
(CD206+, CD11b-) is significantly different than (CD11b+ and CD206+). ns: means no significant difference was observed between (CD11b+ and CD206+) and (CD206-, 
CD11b+). Two-tailed p-value is significant at ≤0.05.
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to post-LGS of 26.9±4.1%, p< 0.0001 (Figure 4A). LGS 
significantly induced the Tregs cell count post-LGS 
expressed as a percentage of total CD4+ cells (3.1±0.4%) 
compared to pre-LGS (1.9±0.3%) at baseline, p<0.0001 
(Figure 4B). Furthermore, counting in the percentage of 
the CD4+T-cells subpopulations to the total CD4+ T cells 
by flow cytometry on isolated PMNLs revealed that LGS 
significantly induced the naïve cell by 1.22 folds from pre- 
LGS (48.3±9.3%) to post-LGS (58.9±9.2%), p< 0.0001, 
and central memory (TCM) cells increased by 1.32 folds 
from pre-LGS (29.0±8.0%) to post-LGS (38.4±9.6%), p< 
0.0001, but effective memory (TEM) cells decreased by 
1.31 folds from pre-LGS (36.8±7.6%) to post-LGS (27.9 
±7.5%), p< 0.0001 among the cohort of class III obesity 
subjects, as shown in Figure 4C. Further, we also observed 
the Tregs cell count post-LGS expressed as a percentage of 
total CD4+ cells (3.1±0.4%) compared to healthy control 
subjects in lean (7.07±2.49%), p< 0.0001 and in healthy 
obese subjects (4.67±1.63%), p= 0.094 – See 
Supplementary Figures (S4). Further, we explored the 
impact of insulin resistance and diabetes on T-reg cells at 
baseline and after LGS of class III obesity subjects, and 
results showed no significant difference at post-LGS was 
observed in obese subjects with andwithout both states of 
insulin resistance and diabetes, p>0.05, See 
Supplementary Figures (S5–S7).
The Relationship Between Treg Cells and 
BMI, Metabolic Profiles, and 
Pro-Inflammatory Cytokines in Class III 
Obesity Group
Further, we evaluated the Spearman’s coefficient correla-
tions (r) between CD4+Treg cells before (B) after (A) of 
LGS, and CD4+ subpopulations at the baseline of naïve, 
effector memory (TEM), and central memory (TCM) at 
baseline with metabolic parameters, adipokines, and che-
mokines, pro-inflammatory cytokines in class III obesity 
group, as shown in Supplementary Tables and Figures 
(Tables S3, S4 and Figure S8).
As displayed in Figure 5(A–D), one of the most important 
correlations observed is the significant inverse correlation 
between leptin, and Treg cells (r=−0.548, p=0.024), indicat-
ing a role of the satiety hormone in regulating the immune 
system (Figure 5A). Figure 5B displays a significant positive 
correlation between IL-10, and naïve cells (r=0.307, 
p=0.008). As shown in Figure 5C and D, hsCRP, and 
MCP-1 display negative relationships with TEM CD4+ 
cells (r=−0.261, p=0.025), and (r=−0.195, p=0.030), respec-
tively. The limited number of study subjects impacts the 
limited correlations detected in the present study.
Discussion
The current study investigated the impact of the surgical 
intervention by the LGS on CD4+ T regulatory cells and 
CD4+ T-lymphocytes subpopulations, which are: naïve, 
TCM, and TEM cells in the peripheral blood of class 111 
obesity subjects after 12 weeks. The major finding of the 
study is the enhancement of the Treg cell counts by ≈1.6 
folds after 12 weeks of LGS in morbidly obese subjects. 
Treg cells’ upsurge was supplemented by a discriminating 
boost of CD4+ naïve and central memory, with a parallel 
decrease of TEM cells and circulating leptin levels after 12 
weeks of LGS. The substantial weight loss and BMI were 
also complemented by a substantial decrease of pro- 
inflammatory cytokines TNF-α, IL-6, and MCP-1, with 
an increase of anti-inflammatory IL-10, likely reflecting 
the pattern characteristic shift from Th1 to Th2 immuno-
phenotyping polarization, from pro-inflammatory to anti- 
inflammatory pattern. Further, LGS reduced the frequency 
of metabolic syndrome (MeS) components along with 





































Figure 3 The total leukocyte count (TLC) and the differential count for granulocytes, 
lymphocytes, and monocytes were counted at the baseline (before) and after 12 weeks 
of the LGS in the class III obesity group. Data are presented as mean and (SD). Two- 
tailed p-value is significant at ≤0.05.
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leptin/adiponectin ratio. Compared to healthy control sub-
jects, T regulatory cells showed upregulation towards 
healthy obese subjects but significantly lower than healthy 
lean subjects. IR and diabetes status has no impact on 
T regulatory cells before and after LGS. The implications 
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Figure 4 The CD4+ T lymphocytes at baseline and 12 weeks after the LGS. (A) A representative of flow cytometry for CD4+ T lymphocytes (CD4+CD45+) before and 
after LGS (left panel). Bars represent mean, and SD of Treg cells, and ****p value (< 0.0001) is significant after 12 weeks of LGS compared to initial bassline levels in class III 
obesity subjects. Two-tailed p value is significant at ≤0.05. (B) T regulatory CD4+ t cells count in class III obesity subjects before and after 12 weeks of LGS. A representative 
of flow cytometry for Treg cells (CD4+CD25+ Foxp3+) before and after LGS (left panel) in class III obesity group. Bars represent mean, and SD of Treg cells, and ****p value 
(< 0.0001) is significant after LGS compared to initial baseline levels. Two-tailed p value is significant at ≤0.05. (C) Naïve and memory CD4+ T cells count in morbidly obese 
subjects before and after LGS. A representative of flow cytometry for naïve and memory CD4+ t cells (left panel). Bars represent mean and SD of naïve, central memory 
(CM) memory, and effector memory (EM) CD4+ T cells. **p value is significant after LGS compared to initial baseline levels in the class III obesity group. Two-tailed p value is 
significant at ≤0.05. 
Abbreviations: B, before LGS surgery at baseline; A, after 12 weeks of LGS surgery.
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The present study demonstrated a marked inflamma-
tory profile characteristic of obese subjects with BMI 
≥ 40kg/m2 at the adipose tissue level and adipokines and 
pro-inflammatory biomarkers’ peripheral circulation. The 
present study demonstrated that AT of class III obesity 
subjects is portrayed by augmented expression of the 
macrophage of CD11b+ (M1 marker) by ≈8.3 folds than 
CD206+ (M2 marker), indicating a distinct inflammatory 
status. Obese subjects are characterized by AT macrophage 
accumulation, which may contribute to systemic insulin 
resistance, and local proliferation of tissue macrophages 
may contribute to risks of adipose tissue homeostasis and 
type 2 DM.11 Two groups of macrophages were initially 
defined typically as activated (M1) and alternatively acti-
vated (M2) macrophages. Macrophage infiltration in AT 
may be a cause and/or a consequence of the low-grade 
inflammatory status in obesity.20 The macrophage profile 
of class III obesity subjects in the present study agrees 
with previous studies demonstrating macrophage infiltra-
tion with M1 polarization in AT of obese subjects.21
Following the LGS, we observed a reduction of the 
circulating inflammatory mediators and cytokines of TNF- 
alpha, IL-6, MCP-1, and hsCRP, which match the signifi-
cant weight loss observed. A previous study demonstrated 
a reduction of MCP-1 following bariatric surgery.22 
Several studies demonstrated that hsCRP seems to be the 
single biomarker of inflammation observed to consistently 
decreased after bariatric surgery.23,24 Furthermore, the pre-
sent study demonstrated a decrease of pro-inflammatory 
cytokines of TNF-alpha and IL-6, which is coherent with 
previous studies,15,17 while other studies demonstrated no 
changes.18,19 The inconsistent results of inflammatory 
cytokines profile between different studies could be due 
to the degree of insulin resistance at baseline, inflamma-
tory markers’ expression, sample size, study design, tech-
nical assays, the timing of assessment of postoperative 
Figure 5 Spearman’s coefficient correlations between CD4+ T lymphocytes’ subpopulations with biomarkers of adiposity and inflammation in class III obesity subjects. (A– 
D) Statistically significant correlations between Treg, naïve, and effector memory CD4+ T cells count in morbidly obese subjects with leptin, IL-10, hsCRP, and MCP-1. 
P value is significant, with a cut off value of ≤0.05 (two-tailed).
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outcomes, and inherited factors of the study population, 
which could impact the heterogeneity among the studies.
The current data demonstrated that the anti- 
inflammatory markers, for instance, adiponectin and 
IL-10, were increased after LGS in the obese subjects, 
consistent with several studies that reported similar find-
ings of these markers after bariatric surgery.15,20 
A previous study by Kalra et al 2017, demonstrated that 
plasma leptin level increases with the fat deposition in 
obese subjects, and a state of leptin resistance is observed 
in morbidly obese subjects due to the failure of signaling 
to the hypothalamic satiety center.21 The present study 
demonstrated a significant reduction of leptin after 12 
weeks of LGS, observed after bariatric surgery in other 
studies such as gastric plication, bypass, and gastric 
sleeve.20,22 The current study demonstrated dramatic 
weight loss after LGS, as previously reported.23 
Adiponectin/leptin ratio increased in obese subjects after 
LGS compared to the baseline by ≈2.9 folds, indicating an 
improvement of adipose tissue dysfunction associated with 
macrophage’s polarization towards M1, insulin resistance, 
and alterations of adipokines, as shown in a previous 
study.23
The present study displays a comprehensive decrease 
in systemic inflammation coupled with a parallel decrease 
in fasting glucose, dyslipidemia, and insulin levels, after 
LGS. These changes are reflected in reduced insulin resis-
tance as assessed by HOMA-index in the cohort Class III 
obese subjects after LGS. Previous studies indicated 
marked improvement post-bariatric surgery in alleviating 
hyperglycemia, hyperinsulinemia, and insulin resistance 
even if obesity is associated with type 2 DM.24,25 The 
frequency of metabolic syndrome components such as 
waist circumference, insulin resistance, dyslipidemia, 
hyperglycemia, and hypertension decreased markedly 
after 12 weeks of LGS among class III obesity subjects. 
Similar studies of follow up after LGS showed similar 
findings of weight loss, improvement of dyslipidemia, 
and metabolic syndrome.26 The mechanisms underlying 
metabolic improvement are poorly understood. These 
mechanisms could be caused by decreased energy intake, 
modification in gut hormone secretion such as peptide YY 
(PYY), glucagon-like peptide (GLP-1), ghrelin, bile acid 
action with activation of GLP-1, and change in gut micro-
biota activity.29 The above paragraphs highlighted that 12 
weeks post-LGS to class 111 obese subjects could improve 
systemic inflammation and alleviates insulin resistance, 
diabetes, and metabolic syndrome.
Treg cells are a minor group of CD4+T lymphocyte 
populations essential for the immune system’s homeosta-
sis, where they can manufacture IL-10 and transforming 
growth factor-beta (TGF-β) to control the inappropriate 
adaptive immune. In vascular adipose tissue (VAT) of 
obese mice, Treg cells had been shown to decrease com-
pared to lean controls, highlighting its possible action in 
obesity-associated inflammation of adipose tissue.30 In 
experimental studies using rats on the high sucrose diet, 
an increase of AT’s oxidative stress was associated with 
decreased Treg cell functions and IL-10 secretions.31 
Moreover, mice deficient in Treg cell in AT is susceptible 
to obesity linked with metabolic syndrome.31 Abundant 
resident T regulatory cells in AT was postulated to have 
a protective role against obesity pathogenesis via affecting 
the metabolism and glucose homeostasis.10
A previous study demonstrated a reduction of the cir-
culating Treg cells in obese subjects and inversely corre-
lated with inflammatory biomarkers, leptin, and BMI.32 
Moreover, a recent study demonstrated a marked reduction 
of Treg lymphocytes, while CD4+ TEM cells increased in 
patients with morbid obesity.33 Children with metabolic 
syndrome demonstrated decreased Treg lymphocytes in 
the peripheral circulation.34 The data presented from the 
previous studies proposed that Treg cells play a significant 
function in suppressing obesity-related inflammation. The 
current study displayed a significant increase in Treg CD4 
+ lymphocytes after LGS in class 111 obese subjects 
compared to the pre-LGS level. Furthermore, our data 
indicated that post-LGS, T reg cell shifted toward healthy 
obese subjects, but less than lean subjects, reflecting an 
improvement of Treg cells.
Moreover, Treg cells’ upregulation post-LGS is not 
related to the insulin resistance or diabetic state, as LGS 
caused a significant increase of Treg cells independently. 
These findings need further analysis with a large sample 
size to confirm its correlation with IR and diabetic state, as 
the sample size is limited. A previous study showed that 
weight loss by 31.2% was observed after 16 weeks of 
laparoscopic greater curvature plication in class 111 obe-
sity subjects associated with parallel decreases in leptin 
and circulating immune cells CD4+ and CD8+ 
T lymphocytes compared to their preoperative values.22 
These data parallel the current study of decreased BMI by 
32.6%, leptin, and CD4+ T lymphocytes. These circula-
tory changes of Treg cell number could mirror changes in 
the microenvironment in VAT, associated with marked loss 
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of body weight and inflammatory status in class 111 obe-
sity subjects.
Human blood CD4+ T lymphocytes are categorized into 
naïve CD45RA+ cells and memory CD45RO+ cells.35 
Moreover, CD27 is expressed by all naïve CD4+ T cells 
and by nearly 80% of the CD4+ memory population. In the 
present study, bariatric surgery provoked changes in the 
T-cell differentiation. In our study, LGS weight loss 
increased naïve cell count, linked with a boost in less- 
differentiated TCM cells but decreased in more differen-
tiated TEM cells. A recent study demonstrated that bariatric 
surgery caused alteration in memory cells with increased 
TCM and decreased EM cells.36 Naïve T cells can react to 
innovative pathogens that the immune system has not yet 
exposed, while memory cells can memorize pathogens and 
enhance the immune response. Naïve T cells can differenti-
ate into memory and antigen-presenting T cells to permit an 
effective secondary response to identical stimuli. CD4+ 
effector memory cells are tangled in the manufacture of pro- 
inflammatory cytokines.37 A previous study demonstrated 
a correlation between TEM cells with pro-inflammatory 
states such as obesity.33
A reduction in peripheral inflammatory markers and 
immune cells was observed after gastric surgery in obese 
subjects.38 In parallel with a previous study, the current 
study’s data demonstrated that weight loss by gastric 
sleeve plus diet restriction shifted T cells phenotype and 
activation.14 Moreover, the marked reduction in pro- 
inflammatory markers, MCP-1, TNF-alpha, and IL-6 with 
a parallel increase in IL-10 (anti-inflammatory) after 
weight loss by LGS mirrors the shift of T cell phenotype 
subpopulations. The shift of Treg, naïve, and memory cells 
after surgery reflect such changes in the inflammatory 
state. These data are coherent with previous results that 
the decrease in Th1/Th2 polarization was correlated with 
weight gain reduction.38,47
The mechanism by which weight loss is induced by 
bariatric surgery in morbid obesity to remodel the immune 
cells is uncertain. We investigated the correlations between 
CD4+T reg cells before and after LGS, as well as its 
subpopulations of naïve, TCM, and TEM cells with the 
metabolic and inflammatory markers. In the present study, 
leptin established a negative relationship with Treg cells at 
baseline, indicating the correlations between leptin and the 
immune system. A previous study reported that in humans, 
leptin negatively affected the proliferation of Foxp3+CD4 
+CD25+ Treg.48 The hsCRP is an acute-phase protein that 
is well known to be associated with chronic low-grade 
inflammation as obesity. In the present study, hsCRP is 
negatively correlated with TEM, which could refer to the 
potential role of hsCRP as a modulator of stimulating the 
proliferation of pro-inflammatory cells, as evident in 
atherosclerosis.49 We identified a positive relationship 
between naïve cells and IL-10 and a negative correlation 
between naïve cells and MCP-1 at baseline. IL-10 is 
a cytokine with numerous impacts on immune system 
instructions and inflammation. IL-10 can impede the pro-
duction of pro-inflammatory cytokines such as IFN-γ, 
IL-2, IL-3, and TNF-α produced by cells such as Treg 
cells, thus defend against tissue inflammation and 
damage.50 MCP-1 or CCL2 is the main monocyte che-
moattractant in vivo and is a major chemotactic and acti-
vating factor of inflammation-associated cells such as 
monocytes/macrophages. The negative correlation with 
naïve cells could impact its proliferation and differentia-
tion functions towards Th2 polarization.51
Limitations
The current study has several limitations, such as the lack 
of a control group undertaking energy restriction by diet 
alone without surgical intervention to cause weight loss. 
The study’s nature as follow up, the sample size is limited, 
and lack of studies addressing the role of other 
T-lymphocytes subset such as CD8+ T lymphocytes. 
Lack of analysis of CD4+ and CD8+ T lymphocytes and 
their subtypes in adipose tissue of morbidly obese subjects 
is one of the major limitations. Further evaluation of AT 
biopsy post-surgery is aanother limitation.
To summarize, the above data indicate that LGS effec-
tively reduces body weight as well as improved abnormal 
metabolic features such as hyperglycemia, dyslipidemia, 
and reduces the frequency of cardiovascular manifesta-
tions such as hypertension and insulin resistance. The 
study revealed that LGS for morbidly obese subjects 
increased the Treg, naïve, and TCM of CD4+ 
T-lymphocytes and decreased CD4+ effector memory 
T-cells. These changes could impact the metabolic, hor-
monal, and inflammatory status associated with weight 
loss by LGS.
Conclusions
This pilot study realized that weight loss after gastric 
sleeve in class 111 obese subjects provokes remarkable 
shifts in immune cell profile, with a subsequent tendency 
towards the anti-inflammatory with cellular immune equi-
librium. Our findings indicated that both the immune 
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systems are creditable to further examination for their 
functions in controlling the metabolism and chronic 
inflammation associated with morbid obesity. It also 
could add knowledge to this area, which is of particular 
interest considering the actual pandemic of Covid-19 that 
put subjects with obesity at a high-risk for severe disease.
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